06-23
Fri
16:15-18:35
分会场四 六楼602B Fourth Parallel Session 602B, 6th floor
脓毒症（免疫调理) -Session2 Sepsis (immunomodulation)-Session2
16:15-16:35
一起走近共识-专家说
管向东 Xiangdong Guan
中山大学附属第一医院 The First Affiliated Hospital, Sun Yat-sen University
姚咏明 Yongming Yao
中国人民解放军总医院转化医学研究中心 TRANSLATIONAL MEDICINE RESEARCH CENTER,THE CHINESE PLA GENERAL HOSPITAL
林洪远 Hongyuan Lin
中国人民解放军总医院第四医学中心 The First Affiliated Hospital of PLA General Hospital
周飞虎 Feihu Zhou
中国人民解放军总医院第一医学中心 The First Medical Center of the PLA General Hospital
张西京 Xijing Zhang
中国人民解放军空军军医大学第一附属医院 Xijing Hospital
16:35-16:55
增强免疫能否预防感染——Trace研究的启示
Can Thymosin Alpha PreventInfection?---lmplications ofTRACE Study
16:55-17:15
脓毒症免疫抑制治疗的现状和展望
Clinical practice of sepsis induced immunosuppression: current immunotherapy and future options
17:15-17:35
Covid-19免疫调理：胸腺肽a1有效吗？
Immunomodulation on Covid-19: Is thymosin α-1 valid?
17:35-17:55
关于免疫调节Covid-19教给我们什么?
What has Covid-19 taught on immunomodulation?
17:55-18:15
训练免疫：改善新生儿脓毒症宿主免疫的潜在途径
TRAINED IMMUNITY: Potential Approaches to Improve the Host Immunity of Neonatal Sepsis
18:15-18:35
脓毒症免疫抑制及免疫调理：十年回顾
lmmunosuppression and immunomodulation in sepsis: retrospect of ten years
Guangzhou Zhongsi Conference Service Co., LTD